May 6, 2020 / By Chris Ciaccia | Fox News As the coronavirus pandemic continues into its sixth month with no cure, the maker of the recently approved drug remdesivir said it is working with companies to expand its manufacturing “through at least 2022.” In an open letter obtained by Fox News, Gilead Sciences said it is working with …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone